J&J To Review Strategies For Growth In Consumer, Medical Device Divisions

(RTTNews) - Johnson & Johnson (JNJ) Wednesday said it will review strategies and opportunities for growth in the Consumer and Medical Device segments.

At a meeting today with the investment community, Johnson & Johnson will highlight the strategic advantages of its broad base in human health care, its holistic approach to innovation and its strategy to achieve above-market growth across the enterprise.

The meeting will also feature new insight into the company's increased focus on leading in the Health-Tech space - the intersection between health care and technology.

Johnson & Johnson has the world's most comprehensive Medical Devices business, with $25.1 billion in total sales for 2015. In its hospital medical device businesses, with plans to file more than 20 major new products through 2018, the company expects to deliver above-market growth within the next year.

The Johnson & Johnson Consumer business has three $1 billion brands today, and expects to expand that to five $1 billion brands by 2020.

The company said its Consumer segment is well positioned to grow sales above the market, while continuing to expand margins to achieve benchmark levels of profitability.